Kanabec County Community Health and Welia Health offer additional COVID-19 Vaccination Clinics
Kanabec County Community Health and Welia Health are currently scheduling appointments for Thursday, April 15th and Thursday, April 22nd. Residents of Kanabec County and/or current Welia Health patients, 16 and older are eligible.
If you are a Kanabec County resident, please call: Ph. (320) 679-6417, 8am - 4:30 pm until clinics are full.
*Please call 320-679-6321 for cancellations.
As of Tuesday, March 30, 2021 - Minnesotans 16+ older are eligible to receive the COVID-19 vaccine.
Note: Providers have been directed to prioritize people in the first of these phases, which includes Minnesotans with specific underlying health conditions; food processing plant workers; and Minnesotans with rare conditions or disabilities that put them at higher risk of severe illness.
For more information, including details about qualifying medical conditions and vaccinations for targeted essential workers, please visit the Minnesota Department of Health website.
The vaccine will be free
The COVID-19 vaccine will be offered at no cost to you. If someone is asking you to pay with a credit card, bank information or cash, it's a scam. The vaccine will be available from many places, like health care providers; vaccine clinics operated by public health departments, community health centers; and at pharmacies.
First vaccines in two shots
The first available COVID-19 vaccines will be a series of two shots. It will require you to get one shot, and then a second shot 3–4 weeks later. It is very important to get both shots to be fully protected.
To make sure you get the right shots in the correct order, get your second shot the same place you got the first one.
To remind yourself when to get the second dose, use the v-safe app.
V-safe is an app where you can quickly tell CDC if you have any side effects after getting the COVID-19 vaccine. Depending on your answers, someone from CDC may call to check on you and get more information.
The vaccine is safe
The first COVID-19 vaccines have been developed by two companies in the United States: Pfizer and Moderna. They have been tested and found to prevent COVID-19 in more than 90 percent of people given the vaccine — a very high rate of effectiveness.
The COVID-19 vaccines that are approved all met strict trial and safety standards. For example, the number of people in COVID-19 vaccine trials is the same as trials for other vaccines in recent years, and they include people from diverse backgrounds.
Both the Pfizer and Moderna vaccines received emergency use authorization (EUA). All vaccines that receive EUA have been strictly tested and continue to receive ongoing safety monitoring.
These vaccines were created quickly because scientists around the world had new technology and a lot of research to build upon. Companies made the vaccine more quickly because the federal government paid for large portions of the work.
The COVID-19 vaccine will be continually studied for side effects and other reporting. If you receive the vaccine, you can help researchers by downloading the v-safe app to report any side effects. For more information on how the vaccines work, go to the Centers for Disease Control and Prevention's Understanding mRNA COVID-19 Vaccines page.
Vaccine safety. (MDH video)
Everyone should continue to educate themselves about the COVID-19 vaccine. Below are some additional COVID-19 vaccine resources to consider:
- 8 things to know about vaccine planning - Centers for Disease Control and Prevention (CDC)
- COVID-19 vaccines - Food and Drug Administration (FDA)
- Why Should I Take the Vaccine? (video) – Black Press USA
- Operation Warp Speed Information Fact Sheet from U.S. Department of Health and Human Services
- Getting factual and scientific information about the COVID-19 vaccine and Operation Warp Speed (OWS) is imperative to making informed decisions. In this 6-minute video OWS is explained as the process by which the vaccine has been studied and eventually approved.
- Find your place in the line for the COVID-19 Vaccination. New York Times Opinion Article in collaboration with other partners.